（Fund9’s portfolio）

Inopase develops the World First closed-loop neuromodulation device to treat overactive bladder.
The device applies the stimulation with the Right Strength at the Right Timing, so that the treatment will be effective to 95% of patients, and 75% of users will be incontinence free while currently 30% of OAB patients develops drug resistance and 60% of patients received the current Sacral neuromodulation still suffers from incontinence.